85 related articles for article (PubMed ID: 2715074)
21. The ribonucleoside diphosphate reductase inhibitor (E)-2'-deoxy-(fluoromethylene)cytidine as a cytotoxic radiosensitizer in vitro.
Coucke PA; Decosterd LA; Li YX; Cottin E; Chen X; Sun LQ; Stern S; Paschoud N; Denekamp J
Cancer Res; 1999 Oct; 59(20):5219-26. PubMed ID: 10537300
[TBL] [Abstract][Full Text] [Related]
22. Analysis of cytidine deaminase and tetrahydrouridine interaction by use of ligand techniques.
Stoller RG; Myers CE; Chabner BA
Biochem Pharmacol; 1978 Jan; 27(1):53-9. PubMed ID: 619907
[No Abstract] [Full Text] [Related]
23. Capacity of deoxycytidine to selectively antagonize cytotoxicity of 5-halogenated analogs of deoxycytidine without loss of antiherpetic activity.
Fox LM; Mekras JA; Bagwell CB; Greer SB
Antimicrob Agents Chemother; 1982 Sep; 22(3):431-41. PubMed ID: 6291452
[TBL] [Abstract][Full Text] [Related]
24. Concentrations of the DNA methyltransferase inhibitor 5-fluoro-2'-deoxycytidine (FdCyd) and its cytotoxic metabolites in plasma of patients treated with FdCyd and tetrahydrouridine (THU).
Beumer JH; Parise RA; Newman EM; Doroshow JH; Synold TW; Lenz HJ; Egorin MJ
Cancer Chemother Pharmacol; 2008 Jul; 62(2):363-8. PubMed ID: 17899082
[TBL] [Abstract][Full Text] [Related]
25. Selective radiosensitization of drug-resistant MutS homologue-2 (MSH2) mismatch repair-deficient cells by halogenated thymidine (dThd) analogues: Msh2 mediates dThd analogue DNA levels and the differential cytotoxicity and cell cycle effects of the dThd analogues and 6-thioguanine.
Berry SE; Davis TW; Schupp JE; Hwang HS; de Wind N; Kinsella TJ
Cancer Res; 2000 Oct; 60(20):5773-80. PubMed ID: 11059773
[TBL] [Abstract][Full Text] [Related]
26. On the interaction of 3,4,5,6-tetrahydrouridine with human liver cytidine deaminase.
Wentworth DF; Wolfenden R
Biochemistry; 1975 Nov; 14(23):5099-105. PubMed ID: 53069
[TBL] [Abstract][Full Text] [Related]
27. Comparison of intravenous and intra-arterial pyrimidine infusion as a means of radiosensitizing tumors in vivo.
Goffinet DR; Brown JM
Radiology; 1977 Sep; 124(3):819-22. PubMed ID: 887782
[TBL] [Abstract][Full Text] [Related]
28. Metabolism and mechanism of action of 5-fluorodeoxycytidine.
Newman EM; Santi DV
Proc Natl Acad Sci U S A; 1982 Nov; 79(21):6419-23. PubMed ID: 6959127
[TBL] [Abstract][Full Text] [Related]
29. Cytotoxic and biochemical effects of thymidine and 3-deazauridine on human tumor cells.
Lockshin A; Mendoza JT; Giovanella BC; Stehlin JS
Cancer Res; 1984 Jun; 44(6):2534-9. PubMed ID: 6722792
[TBL] [Abstract][Full Text] [Related]
30. Antiviral iodinated pyrimidine deoxyribonucleosides: 5-iodo-2'-deoxyuridine; 5-iodo-2'-deoxycytidine; 5-iodo-5'-amino-2',5'-dideoxyuridine.
Prusoff WH; Chen MS; Fischer PH; Lin TS; Shiau GT; Schinazi RF; Walker J
Pharmacol Ther; 1979; 7(1):1-34. PubMed ID: 392550
[No Abstract] [Full Text] [Related]
31. The mismatch repair protein, hMLH1, mediates 5-substituted halogenated thymidine analogue cytotoxicity, DNA incorporation, and radiosensitization in human colon cancer cells.
Berry SE; Garces C; Hwang HS; Kunugi K; Meyers M; Davis TW; Boothman DA; Kinsella TJ
Cancer Res; 1999 Apr; 59(8):1840-5. PubMed ID: 10213489
[TBL] [Abstract][Full Text] [Related]
32. Enhancement by tetrahydrouridine (NSC-112907) of the oral activity of 5-azacytidine (NSC-102816) in L1210 leukemic mice.
Neil GL; Moxley TE; Kuentzel SL; Manak RC; Hanka LJ
Cancer Chemother Rep; 1975; 59(3):459-65. PubMed ID: 54211
[TBL] [Abstract][Full Text] [Related]
33. The impact of selected nucleosides on the cytotoxicity of Ara-C in HL60 cells.
Mejer J
Adv Exp Med Biol; 1991; 309A():97-100. PubMed ID: 1789277
[No Abstract] [Full Text] [Related]
34. Effect of tetrahydrouridine on the action of 1-beta-D-arabinofuranosylcytosine in synchronized cultures of normal rat kidney cells.
Wan CW; Mak TW
Cancer Res; 1979 Oct; 39(10):3981-5. PubMed ID: 476637
[TBL] [Abstract][Full Text] [Related]
35. Purification and properties of cytidine deaminase from normal and leukemic granulocytes.
Chabner BA; Johns DG; Coleman CN; Drake JC; Evans WH
J Clin Invest; 1974 Mar; 53(3):922-31. PubMed ID: 4521417
[TBL] [Abstract][Full Text] [Related]
36. The dependence of halogenated pyrimidine incorporation and radiosensitization on the duration of drug exposure.
Lawrence TS; Davis MA; Maybaum J; Stetson PL; Ensminger WD
Int J Radiat Oncol Biol Phys; 1990 Jun; 18(6):1393-8. PubMed ID: 2370189
[TBL] [Abstract][Full Text] [Related]
37. Comparative studies of the cytostatic action and metabolism of 5-azacytidine and 5,6-dihydro-5-azacytidine.
Voytek P; Beisler JA; Abbasi MM; Wolpert-DeFilippes MK
Cancer Res; 1977 Jul; 37(7 Pt 1):1956-61. PubMed ID: 67884
[TBL] [Abstract][Full Text] [Related]
38. 5-Iododeoxyuridine increases the efficacy of the radioimmunotherapy of human tumors growing in nude mice.
Santos O; Pant KD; Blank EW; Ceriani RL
J Nucl Med; 1992 Aug; 33(8):1530-4. PubMed ID: 1634946
[TBL] [Abstract][Full Text] [Related]
39. Potentiation of cytotoxicity and radiosensitization of (E)-2-deoxy-2'-(fluoromethylene) cytidine by pentoxifylline in vitro.
Li YX; Sun LQ; Weber-Johnson K; Paschoud N; Coucke PA
Int J Cancer; 1999 Jan; 80(1):155-60. PubMed ID: 9935246
[TBL] [Abstract][Full Text] [Related]
40. Enzymatic basis for the selective inhibition of varicella-zoster virus by 5-halogenated analogues of deoxycytidine.
Dobersen MJ; Jerkofsky M; Greer S
J Virol; 1976 Nov; 20(2):478-86. PubMed ID: 185427
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
